PPT-Treating Psoriasis: A Guide to Understanding Biologics

Marlee R Steele DNP RN FNPBC Disclosures I have no financial disclosures related to this lecture Brand names as well as generic names are provided in the context of this talk for clarity Learning Objectives. 1. PEG Nanoparticles: . Production . and Drug Delivery. Structure and Function. Principles of the . NanoKit. :. A Laboratory Educational Tool . Syed K. Hasan M.D. . Ph.D. CEO/President. . Arthur . a Virtual Biologics Clinic. Dr Ben Parker PhD, MRCP. Consultant Rheumatologist, Manchester Royal Infirmary. Honorary Senior Lecturer, University of Manchester. To cover. Why the need for innovation in biologics services?. Presented by:. Paige Barry . &. Chloe Janson. What is Psoriasis?. Chronic skin disease that causes a rapid growth of skin cells.. What are Symptoms of Psoriasis?. What is the Epidemiology of Psoriasis?. Press Conference. 28 October 2014. Welcome. Prof. . Myrto. . Trakatelli. Dermatologist. Miss . Dufourny. Dominique . Alderwomen of Ixelles. Prof Erwin . Tschachler. . Presentation of the Campaign. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Animation: What Are Biologics?. Production of Biologics. Sources of Variation in Biologics. Variability Is a Natural and Expected Property of All Biologics. Glycosylation Affects Protein Properties. Most Biologics Have Undergone Manufacturing Changes. An expanded histopathologic spectrum of psoriasis: review of 51 clinically confirmed cases Thinh Chau, Kory K. Parsi , Toru Ogawa, Maija Kiuru , Thomas Konia, Maxwell A. Fung Introduction Introduction: INTRODUCTION. Psoriasis is a chronic inflammatory papulosquamous disease characterized by multiple remissions and relapses. For long, it was believed to be primarily a disorder of keratinization. In the past decade researchers have come up with new factors that may be involved in the pathogenesis of disease, but they have failed to establish a . . Hasan. M.B.CH.B. C.A.B.S-D.V. Psoriasis is a chronic, non-infectious, inflammatory skin disorder, characterized by well-defined . salmonpink. . plaques bearing large adherent silvery centrally attached scales.. Abid. . Psoriasis Description. Inflammatory, common, chronic, . genodermatosis. which appears to be due abnormal t lymphocytes function. may be affected Skin, nails and joints forms.. There are several distinct clinical type . Tamara Arabiyat. Psoriasis is a chronic inflammatory systemic autoimmune disease.. Globally, 1-2% of the population is affected by psoriasis.. Prevalence is equal in males and females.. In monozygotic twins, if one twin has the disease, the other one has a 70% chance of being affected. In dizygotic twins, there is only a 20% chance. . Psoriasis is a noncontagious skin disorder that most commonly appears as inflamed, edematous skin lesions covered with a silvery white scale. The most common type of psoriasis is plaque psoriasis . Causes . What does personalisation . mean . for you?. Ian N Bruce. Kellgren. Centre for Rheumatology. NIHR . Manchester Biomedical Research . Centre University of Manchester . @. Lupusdoc. Manchester University Hospitals NHS Trust and University of Manchester. Index nursing college . indore. introduction. Psoriasis is a skin disease that causes a rash with itchy, scaly patches, most commonly on the knees, elbows, trunk and scalp. Psoriasis is a common, long-term (chronic) disease with no cure. It can be painful, interfere with sleep and make it hard to concentrate.